跳至主要内容
临床试验/NCT01242332
NCT01242332已完成4 期

Perioperative Administration of Pregabalin in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction: Does it Help to Relieve Postoperative Pain?

Prince of Songkla University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
efficacy

研究概览

简要总结

To prove pregabalin's efficacy and safety in Thai patients scheduled for arthroscopic ACL reconstruction

详细描述

Only eligible patients with willingness to join this study are included. Eligible patients are those aged 18-65 years of either sex, American Society of Anesthesiologists (ASA) physical status I & II, and body mass index (BMI) between 16-35. The exclusion criteria are patients who are allergic to pregabalin, with impaired hepatic and renal functions, alcohol or substance abuse, chronic pain (except pain in the knee joint) or daily intake of analgesics, uncontrolled medical disease (hypertension and diabetes mellitus) and inability to operate patient-controlled analgesia (PCA) device.

Data analysis

  • Student t-test for continuous data with normal distribution
  • Mann-Whitney U test for continuous data with non-normal distribution
  • Chi-square test for categorical data

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible patients are those aged 18-65 years of either sex,
  • American Society of Anesthesiologists (ASA) physical status I & II, and body mass index (BMI) between 16-35.

排除标准

  • patients who are allergic to pregabalin,
  • impaired hepatic and renal functions,
  • alcohol or substance abuse,
  • chronic pain (except pain in the knee joint) or daily intake of analgesics, uncontrolled medical disease (hypertension and diabetes mellitus)
  • inability to operate patient-controlled analgesia (PCA) device

研究组 & 干预措施

Pregabalin

Experimental

75 mg po 2 hrs before surgery

干预措施: Pregabalin (Drug)

结局指标

主要结局

efficacy

时间窗: August 2009 - January 2011

efficacy of postoperative pain management

次要结局

  • safety(August 2009 - January 2011)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验